The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats

References

• FA Pieters, and J Zuidema. The absolute oral bioavailability of dapsone in dogs and humans. Int J Clin Pharmacol Ther Toxicol 1987; 25:396–400.
   PubMed Web of Science ®Google Scholar
• U Paniker, and N Levine. Dapsone and sulfapyridine. Dermatol Clin 2001; 19:79–86.
   PubMed Web of Science ®Google Scholar
• PM Girad, R Landman, C Gaudebout, R Olivares, AG Saimot, P Jelazko, A Certain, F Boue, E Bouvet, T Lecompte, and JP Coulaud. the PRIO Study Group. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328:1514–1520.
   PubMed Web of Science ®Google Scholar
• H Uehleke, and S Tabarelli. N-hydroxylation of 4,4´-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans. Naunyn Schmiedebergs Arch Pharmacol 1973; 278:55–68.
   PubMed Web of Science ®Google Scholar
• PB Watkins. Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994; 4:171–184.
   PubMedGoogle Scholar
• WR Malfara, CP Pereira, A Cardozo, D Santos, and RHC Queiroz. Effects of H2-receptor antagonists on dapsone-induced methemoglobinemia in rats. Pharm Res 2002; 45:269–273.
   Web of Science ®Google Scholar
• AK Mitra, KE Thummel, TF Kalhorn, ED Kharasch, JD Unadkat, and JT Slattery. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther 1995; 58:556–566.
   PubMed Web of Science ®Google Scholar
• MD Coleman, LE Rhodes, AK Scott, JL Verbov, PS Friedmann, AM Breckenridge, and BK Park. The use of cimetidine to reduce dapsone-dependent methaemoglobinemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 1992; 34:244–249.
   PubMed Web of Science ®Google Scholar
• RO Wright, WJ Lewander, and AD Woolf. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34:646–656.
   PubMed Web of Science ®Google Scholar
• ER Jaffe, and DE Hultquist. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. CR Scriver, AL Beaudet, WS Sly, and et al, and The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York: McGraw-Hill; 1995: 2267–2280.
   Google Scholar
• S Curry. Methemoglobinemia. Ann Emerg Med 1982; 11:214–221.
   PubMed Web of Science ®Google Scholar
• A Mansouri, and AA Lurie. Concise review: methemoglobinemia. Am J Hematol 1993; 42:7–12.
   PubMed Web of Science ®Google Scholar
• JW Harvey, and AS Keitt. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia. Br J Haematol 1983; 54:29–41.
   PubMed Web of Science ®Google Scholar
• PJ Rosen, C Johnson, WG McGehee, and E Beutler. Failure of methylene blue treatment in toxic methemoglobinemia. Ann Intern Med 1971; 75:83–86.
   PubMed Web of Science ®Google Scholar
• IR Kirsch, and HJ Cohen. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr 1980; 96:276–278.
   PubMed Web of Science ®Google Scholar
• J O'Donnell-Tormey, CF Nathan, K Lanks, CJ DeBoer, and J de la Harpe. Secretion of pyruvate: an antioxidant defense of mammalian cells. J Exp Med 1987; 165:500–514.
   PubMed Web of Science ®Google Scholar
• K Brand. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 1997; 29:355–364.
   PubMed Web of Science ®Google Scholar
• KA Brand, and U Hermfisse. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997; 11:388–395.
   PubMed Web of Science ®Google Scholar
• KA Nath, EO Ngo, RP Hebbel, AJ Croatt, B Zhou, and LM Nutter. α-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am J Physiol 1995; 268:C227–C236.
   PubMedGoogle Scholar
• P Dobsak, C Courdertot-Masuyer, M Zeller, C Vergely, A Laubriet, M Assem, JC Eicher, JR Teyssier, JE Wolf, and L Rochette. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 1999; 34:651–659.
   PubMed Web of Science ®Google Scholar
• E Bassenge, O Sommer, M Schwemmer, and R Bunger. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 2000; 279:H2431–2438.
   PubMed Web of Science ®Google Scholar
• MP Fink. Ethyl pyruvate: a novel anti-inflammatory agent. Crit Care Med 2003; 31:S51–S56.
   PubMed Web of Science ®Google Scholar
• CM Montgomery, and JL Webb. Metabolic studies on heart mitochondria: II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. J Biol Chem 1956; 221:359–368.
   PubMed Web of Science ®Google Scholar
• JL Willems, AF de Kort, TB Vree, JM Trijbels, JH Veerkamp, and LA Monnens. Non-enzymatic conversion of pyruvate in aqueous solution to 2,4-dihydroxy-2-methylglutaric acid. FEBS Lett 1978; 86:42–44.
   PubMed Web of Science ®Google Scholar
• MC Reade, and MP Fink. Bench-to-bedside review: amelioration of acute renal impairment using ethyl pyruvate. Crit Care 2005; 9:556–560.
   PubMed Web of Science ®Google Scholar
• RO Wright, B Magnani, MW Shannon, and AD Woolf. N-acetylcysteine reduces methemoglobin in vitro. Ann Emerg Med 1996; 28:499–503.
   PubMed Web of Science ®Google Scholar
• RO Wright, AD Woolf, MW Shannon, and B Magnani. N-acetylcysteine reduces methemoglobin in an in vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med 1998; 5:225–229.
   PubMed Web of Science ®Google Scholar
• DA Tanen, F LoVecchio, and SC Curry. Failure of intravenous N-acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: a randomized controlled trial. Ann Emerg Med 2000; 35:369–373.
   PubMed Web of Science ®Google Scholar
• J Dotsch, S Demirakca, A Cryer, J Hanze, PG Kuhl, and W Rascher. Reduction of NO-induced methemoglobinemia requires extremely high doses of ascorbic acid in vitro. Intensive Care Med 1998; 24:612–615.
   PubMed Web of Science ®Google Scholar
• MJ Matteucci, WJ Reed, and DA Tanen. Sodium thiosulfate fails to reduce nitrite-induced methemoglobinemia in vitro. Acad Emerg Med 2003; 10:299–302.
   PubMed Web of Science ®Google Scholar
• JG Linakis, M Shannon, A Woolf, and C Sax. Recurrent methemoglobinemia after acute dapsone intoxication in a child. J Emerg Med 1989; 7:477–480.
   PubMedGoogle Scholar